A new study led by Dr. Larry Lands was recently published in the Journal of Cystic Fibrosis 2016. The study, led by a team from the Research Institute of the McGill University Health Centre (RI-MUHC) and Cystic Fibrosis Canada, reinforces the benefits of newborn screening for Cystic Fibrosis patients. Children with Cystic Fibrosis who are diagnosed through newborn screening are healthier and benefit more from new treatments.
About the study
The study, “The benefits of newborn screening for cystic fibrosis: The Canadian experience” was co-written by D.Y.F. Mak (Cystic Fibrosis Canada, Toronto, Canada), J. Sykes (Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Canada), A.L. Stephenson (Keenan Research Centre, Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Toronto, Canada), and L.C. Lands (Research Institute of the McGill University Health Centre, Montreal, Canada).
This work was made possible through the in-kind support from Cystic Fibrosis Canada.
View articles and interviews about this research:
- Opinion: Quebec should screen newborns for cystic fibrosis. Earlier diagnosis helps patients avoid damage, leads to fewer hospitalizations, and is cost-effective for the health-care system. Special to Montreal Gazette. Larry Lands. May 4, 2017.
- Cystic fibrosis: Promising advances showcased in Montreal. Montreal symposium showcases promising advances, including gene splicing, stem cell therapies and new medications targeting specific mutations. Montreal Gazette. by Charlie Fidelman. May 13, 2016.
- Newborn screening for cystic fibrosis. McGill Reporter. May 5, 2016.
- Quebec children suffer from lack of neonatal screening in cystic fibrosis. Montreal Gazette. By Charlie Fidelman. May 6, 2016.
- New study reinforces importance of implementing newborn screening for cystic fibrosis in Quebec. MUHC News. May 4, 2016.
- Neuf ans avant d’obtenir un diagnostic de fibrose kystique. Journal Métro. By Roxane Léouzon. May 4, 2016.